Main Text {#Sec1}
=========

We read with great interest the analysis by Smith et al. \[[@CR1]\] on the correlation between duration of veno-arterial extracorporeal life support (VA-ECMO) and outcomes, using data from the extracorporeal life support organization (ELSO). We note their finding that decannulation at day four of VA-ECMO is associated with the highest percentage of patients surviving.

While this is the largest analysis of VA-ECMO duration to date, it is limited by use of a retrospective database that appears to offer inadequate detail on cannulation strategies. As with any multivariate logistic regression performed on an observational dataset, the results need to be interpreted in the context of availability of adequate data on confounding variables. We would argue that cannulation site, whether central cannulation or peripheral cannulation, is a significant confounding variable when assessing survival on VA-ECMO \[[@CR2]\]. Similarly, strategies to decompress the left ventricle are critical in optimizing survival on VA-ECMO. Techniques such as left ventricular venting, intra-aortic balloon pump placement, or the Impella ® (Abiomed, Danvers, MA) are commonly employed in this setting and should be accounted for in the statistical analysis \[[@CR3]\].

We would encourage the ELSO group to work to improve data collection around the use of these techniques, to facilitate improved statistical analysis and a better understanding of the implications of placing patients on VA-ECMO for prolonged periods of time.

ELSO

:   Extracorporeal life support organization

VA-ECMO

:   Veno-arterial extracorporeal life support

See related research by Smith et al., <https://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1633-1>

This comment refers to the article available at: <https://doi.org/10.1186/s13054-017-1633-1>.
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We thank Drs. Kiefer and Freundlich, who correctly comment that any retrospective analysis of a database, such as the ELSO registry, is limited by the persistence of confounding variables. We agree that cannulation strategy, as well as other techniques mentioned, such as left ventricular venting and intra-aortic balloon pump placement, may have an impact on both treatment duration and survival.

While the ELSO registry allows for collection of many disease-, patient-, and treatment-related variables \[[@CR4]\], we had to focus on key covariates that were anticipated to occur commonly and influence duration and survival. While cannulation site data may be available from the data collected, use of other devices to "vent" the left ventricle or facilitate weaning is not (other than a statement on whether the patient was "converted to other support"). There is a challenge for data collection to be both complete and standardized. Currently, there is no agreed upon standard of care for the use of venting, new approaches to venting are reported frequently, and new devices are being introduced. We agree that this should be a focus of further research, in particular to delineate the role of left ventricular decompression for which a variety of strategies are reported with only few reports to date on their effect on duration and outcome \[[@CR5], [@CR6]\].
